See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

Presenter: Byoung Kwon Lee

October 29, 2013

Presentation TCT 2013

TCT-68. Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study

Presenter: Bernhard Witzenbichler

October 29, 2013

Presentation TCT 2013

Small Molecules and mi-RNAs

Presenter: Stefanie Dimmeler

October 29, 2013

Presentation TCT 2013

Transcatheter Aortic Valve Implantation In Patients With Severe Aortic Valve Stenosis and Large Aortic Annulus, Using the Self-Expanding 31-mm Medtronic CoreValve Prosthesis: First Clinical Experience

Presenter: Freek Nijhoff

October 29, 2013

Presentation TCT 2013

Case Presentation 3: Primary PCI with a Complex Bifurcation of the Left Main

Presenter: Miroslav Vytiska

October 29, 2013

Presentation TCT 2013

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Presenter: Yuejin Yang

October 29, 2013

Presentation TCT 2013

CoreValve US Pivotal Study Design and Extreme Risk Results

Presenter: Steven Yakubov

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: Treatment Considerations in a Symptomatic HCM Patient with Large Residual Gradient After Septal Ablation

Presenter: Srihari Naidu

October 29, 2013

Presentation TCT 2013

Interim results of the JUPITER Registry on long-term performance and safety of the Transapical JenaValve

Presenter: Stephan Ensminger

October 29, 2013

Presentation TCT 2013

TAVR Migration from Inoperable to Moderate Risk Patients: Practice and Caveats

Presenter: Christian Hamm

October 29, 2013

Advertisement

Slides

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

TCT-68. Does IVUS Reduce Stent Thrombosis with DES? Two-year results from the prospective, multicenter ADAPT-DES study

Small Molecules and mi-RNAs

Transcatheter Aortic Valve Implantation In Patients With Severe Aortic Valve Stenosis and Large Aortic Annulus, Using the Self-Expanding 31-mm Medtronic CoreValve Prosthesis: First Clinical Experience

Case Presentation 3: Primary PCI with a Complex Bifurcation of the Left Main

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

CoreValve US Pivotal Study Design and Extreme Risk Results

Case Presentation and Topic Review: Treatment Considerations in a Symptomatic HCM Patient with Large Residual Gradient After Septal Ablation

Interim results of the JUPITER Registry on long-term performance and safety of the Transapical JenaValve

TAVR Migration from Inoperable to Moderate Risk Patients: Practice and Caveats

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content